LSO Knowledge and Networking Breakfast - Health System Readiness in the Era of Cell and Gene Therapy - From Benchtop to Bedside

This discussion will focus on the adoption of cell and gene therapies within the health system and explore the path from discovery to delivery, including the commercialization challenges of scaling therapies from benchtop to clinic, emerging innovations such as antibody–drug conjugates and personalized medicine, and the evolving Canadian investment landscape supporting the growth of advanced therapies.

Dr. Mary Argent-Katwala, Senior Director, Stakeholder Engagement at OBIO®, will be attending the event.